{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:47:30Z","timestamp":1790207250074,"version":"4.1.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:00:00Z","timestamp":1539043200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS038261"],"award-info":[{"award-number":["NS038261"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS081121"],"award-info":[{"award-number":["NS081121"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS106902"],"award-info":[{"award-number":["NS106902"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"DOI":"10.3389\/fnmol.2018.00383","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T01:10:46Z","timestamp":1539047446000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Group II Metabotropic Glutamate Receptors: Role in Pain Mechanisms and Pain Modulation"],"prefix":"10.3389","volume":"11","author":[{"given":"Mariacristina","family":"Mazzitelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Palazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabatino","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Neugebauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-6-60","article-title":"Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity\/transmission in the amygdala in a mouse inflammatory pain model.","volume":"6","author":"Adedoyin","year":"2010","journal-title":"Mol. Pain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nbd.2014.11.012","article-title":"Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.","volume":"74","author":"Battaglia","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-77","article-title":"N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors.","volume":"8","author":"Bernabucci","year":"2012","journal-title":"Mol. Pain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1021\/acsmedchemlett.7b00279","article-title":"Design and synthesis of mGlu2 NAMs with improved potency and CNS penetration based on a truncated picolinamide core.","volume":"8","author":"Bollinger","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0028-3908(98)00091-4","article-title":"Comparative effect of L-CCG-I, DCG-IV and \u03b3-carboxy-L-glutamate on all cloned metabotropic glutamate receptor subtypes.","volume":"37","author":"Brabet","year":"1998","journal-title":"Neuropharmacology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1136\/gutjnl-2014-307748","article-title":"Epigenetic upregulation of metabotropic glutamate receptor 2 in the spinal cord attenuates oestrogen-induced visceral hypersensitivity.","volume":"64","author":"Cao","year":"2015","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1124\/mol.110.067488","article-title":"Targeting group-II metabotropic glutamate receptors for the treatment of psychosis associated with Alzheimer\u2019s disease: selective activation of mGlu2 receptors amplifies \u03b2-amyloid toxicity in cultured neurons whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective.","volume":"79","author":"Caraci","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12727","DOI":"10.1523\/JNEUROSCI.6558-10.2011","article-title":"Group II\/III metabotropic glutamate receptors exert endogenous activity-dependent modulation of TRPV1 receptors on peripheral nociceptors.","volume":"31","author":"Carlton","year":"2011","journal-title":"J. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.eplepsyres.2013.10.009","article-title":"Activation of group 2 metabotropic glutamate receptors reduces behavioral and electrographic correlates of pilocarpine induced status epilepticus.","volume":"108","author":"Caulder","year":"2014","journal-title":"Epilepsy Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.apha.2015.11.001","article-title":"Modulation of chronic pain by metabotropic glutamate receptors.","volume":"75","author":"Chiechio","year":"2016","journal-title":"Adv. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1124\/mol.61.5.989","article-title":"L-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors.","volume":"61","author":"Chiechio","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.coph.2011.10.010","article-title":"Metabotropic glutamate receptors and the control of chronic pain.","volume":"12","author":"Chiechio","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1124\/mol.108.054346","article-title":"Epigenetic modulation of mGlu2 receptors by histone deacetylase inhibitors in the treatment of inflammatory pain.","volume":"75","author":"Chiechio","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd2760","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders.","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1113\/jphysiol.2011.218065","article-title":"Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus.","volume":"590","author":"Copeland","year":"2012","journal-title":"J. Physiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2017.04.019","article-title":"Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation.","volume":"121","author":"Copeland","year":"2017","journal-title":"Neuropharmacology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1097\/j.pain.0000000000000621","article-title":"Group II mGluRs suppress hyperexcitability in mouse and human nociceptors.","volume":"157","author":"Davidson","year":"2016","journal-title":"Pain"},{"key":"B18","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1021\/jm1012165","article-title":"Design and synthesis of an orally active metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulator (PAM) that decreases cocaine self-administration in rats.","volume":"54","author":"Dhanya","year":"2010","journal-title":"J. Med. Chem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuropharm.2017.10.026","article-title":"Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.","volume":"128","author":"Di Menna","year":"2018","journal-title":"Neuropharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2217\/nmt.12.6","article-title":"Therapeutic potential of targeting metabotropic glutamate receptors for Parkinson\u2019s disease.","volume":"2","author":"Dickerson","year":"2012","journal-title":"Neurodegener. Dis. Manag."},{"key":"B21","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.neuroscience.2008.03.084","article-title":"Group II metabotropic glutamate receptor activation attenuates peripheral sensitization in inflammatory states.","volume":"154","author":"Du","year":"2008","journal-title":"Neuroscience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/sj.npp.1301531","article-title":"Efficacy and tolerability of an mGlu2\/3 agonist in the treatment of generalized anxiety disorder.","volume":"33","author":"Dunayevich","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7485","DOI":"10.1021\/acs.jmedchem.5b01005","article-title":"Discovery of a selective and CNS penetrant negative allosteric modulator of metabotropic glutamate receptor subtype 3 with antidepressant and anxiolytic activity in rodents.","volume":"58","author":"Engers","year":"2015","journal-title":"J. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.neuropharm.2009.11.014","article-title":"Activation of metabotropic glutamate (mGlu) 2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge.","volume":"58","author":"Fell","year":"2010","journal-title":"Neuropharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/jpet.110.172957","article-title":"N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl) phenoxy) methyl) benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic\/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes.","volume":"336","author":"Fell","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.brainres.2007.12.057","article-title":"Distribution of metabotropic glutamate 2 and 3 receptors in the rat forebrain: implication in emotional responses and central disinhibition.","volume":"1197","author":"Gu","year":"2008","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-015-0139-5","article-title":"Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice.","volume":"8","author":"Guida","year":"2015","journal-title":"Mol. Brain"},{"key":"B28","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-2-18","article-title":"Enhanced group II mGluR-mediated inhibition of pain-related synaptic plasticity in the amygdala.","volume":"2","author":"Han","year":"2006","journal-title":"Mol. Pain"},{"key":"B29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0306-4522(97)00183-8","article-title":"Block of theta-burst-induced long-term potentiation by (1S, 3S)-1-aminocyclopentane-1, 3-dicarboxylic acid: further evidence against long-term potentiation as a model for learning.","volume":"81","author":"H\u00f6lscher","year":"1997","journal-title":"Neuroscience"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1523\/JNEUROSCI.0995-04.2004","article-title":"Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.","volume":"24","author":"Hou","year":"2004","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/ejn.12432","article-title":"CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model.","volume":"39","author":"Ji","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1523\/JNEUROSCI.0225-10.2010","article-title":"Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation.","volume":"30","author":"Ji","year":"2010","journal-title":"J. Neurosci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00213-004-2099-9","article-title":"Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model (s).","volume":"179","author":"Johnson","year":"2005","journal-title":"Psychopharmacology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/bph.13740","article-title":"Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2\/3 receptor agonist LY2934747, in rodent pain models.","volume":"174","author":"Johnson","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","article-title":"The glutamate homeostasis hypothesis of addiction.","volume":"10","author":"Kalivas","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2015.03.016","article-title":"Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2\/3 receptor agonist pomaglumetad methionil in schizophrenia.","volume":"78","author":"Kinon","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1523\/JNEUROSCI.4047-15.2016","article-title":"Rescue of impaired mGluR5-driven endocannabinoid signaling restores prefrontal cortical output to inhibit pain in arthritic rats.","volume":"36","author":"Kiritoshi","year":"2016","journal-title":"J. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.neuropharm.2015.04.003","article-title":"Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.","volume":"95","author":"Kiritoshi","year":"2015","journal-title":"Neuropharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1021\/acschemneuro.8b00022","article-title":"Pathway-specific alterations of cortico-amygdala transmission in an arthritis pain model.","volume":"9","author":"Kiritoshi","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/bs.pmbts.2014.12.003","article-title":"mGluRs head to toe in pain.","volume":"131","author":"Kolber","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1152\/jn.00495.2006","article-title":"Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.","volume":"96","author":"Li","year":"2006","journal-title":"J. Neurophysiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0028-3908(98)00126-9","article-title":"Characterisation of mGluRs which modulate nociception in the PAG of the mouse.","volume":"37","author":"Maione","year":"1998","journal-title":"Neuropharmacology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0304-3959(99)00269-9","article-title":"Periaqueductal gray matter metabotropic glutamate receptors modulate formalin-induced nociception.","volume":"85","author":"Maione","year":"2000","journal-title":"Pain"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-017-0293-z","article-title":"Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.","volume":"10","author":"Maksymetz","year":"2017","journal-title":"Mol. Brain"},{"key":"B45","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/349760a0","article-title":"Sequence and expression of a metabotropic glutamate receptor.","volume":"349","author":"Masu","year":"1991","journal-title":"Nature"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2174\/138920111798357438","article-title":"Metabotropic glutamate receptors as targets for analgesia: antagonism, activation, and allosteric modulation.","volume":"12","author":"Montana","year":"2011","journal-title":"Curr. Pharm. Biotechnol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejphar.2010.01.030","article-title":"Group II metabotropic glutamate receptors (mGlu2\/3) in drug addiction.","volume":"639","author":"Moussawi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00130","article-title":"Group II metabotropic glutamate receptors as targets for novel antipsychotic drugs.","volume":"7","author":"Muguruza","year":"2016","journal-title":"Front. Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1471-4159.2011.07380.x","article-title":"N-Acetylaspartylglutamate is an agonist at mGluR3 in vivo and in vitro.","volume":"119","author":"Neale","year":"2011","journal-title":"J. Neurochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1046\/j.1471-4159.2000.0750443.x","article-title":"N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.","volume":"75","author":"Neale","year":"2000","journal-title":"J. Neurochem."},{"key":"B51","first-page":"477","article-title":"The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.","volume":"26","author":"Neale","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(00)01613-X","article-title":"Antinociceptive effect of a group II metabotropic glutamate receptor antagonist in the thalamus of monoarthritic rats.","volume":"296","author":"Neto","year":"2000","journal-title":"Neurosci. Lett."},{"key":"B53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-540-33823-9_8","article-title":"Glutamate receptor ligands.","volume":"177","author":"Neugebauer","year":"2007","journal-title":"Handb. Exp. Pharmacol."},{"key":"B54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/978-1-59745-055-3_12","article-title":"\u201cGroup III metabotropic glutamate receptors (mGlu4, mGlu6, mGlu7, and mGlu8),\u201d in","author":"Neugebauer","year":"2008","journal-title":"The Glutamate Receptors"},{"key":"B55","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/978-3-642-28753-4_2381","article-title":"\u201cMetabotropic glutamate receptors in spinal nociceptive processing,\u201d in","author":"Neugebauer","year":"2013","journal-title":"Encyclopedia of Pain"},{"key":"B56","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/978-3-662-46450-2_13","article-title":"Amygdala pain mechanisms.","volume":"227","author":"Neugebauer","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1152\/jn.2000.84.6.2998","article-title":"Groups II and III metabotropic glutamate receptors differentially modulate brief and prolonged nociception in primate STT cells.","volume":"84","author":"Neugebauer","year":"2000","journal-title":"J. Neurophysiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.brainresrev.2008.12.014","article-title":"Forebrain pain mechanisms.","volume":"60","author":"Neugebauer","year":"2009","journal-title":"Brain Res. Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1177\/1073858403261077","article-title":"The amygdala and persistent pain.","volume":"10","author":"Neugebauer","year":"2004","journal-title":"Neuroscientist"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.neuropharm.2010.10.022","article-title":"Metabotropic glutamate receptors: from the workbench to the bedside.","volume":"60","author":"Nicoletti","year":"2011","journal-title":"Neuropharmacology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coph.2014.12.002","article-title":"Metabotropic glutamate receptors as drug targets: what\u2019s new?","volume":"20","author":"Nicoletti","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/jpm6010009","article-title":"Serotonin 2A receptor SNP rs7330461 association with treatment response to pomaglumetad methionil in patients with schizophrenia.","volume":"6","author":"Nisenbaum","year":"2016","journal-title":"J. Pers. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease.","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1744806917697008","article-title":"A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ-43 and 2-PMPA.","volume":"13","author":"Nonaka","year":"2017","journal-title":"Mol. Pain"},{"key":"B65","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/YPG.0000000000000050","article-title":"The functional GRM3 Kozak sequence variant rs148754219 affects the risk of schizophrenia and alcohol dependence as well as bipolar disorder.","volume":"24","author":"O\u2019brien","year":"2014","journal-title":"Psychiatr. Genet."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1007\/s11064-017-2181-4","article-title":"NAAG peptidase inhibitors act via mglur3: animal models of memory, Alzheimer\u2019s, and ethanol intoxication.","volume":"42","author":"Olszewski","year":"2017","journal-title":"Neurochem. Res."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1130-9","article-title":"Role of the prefrontal cortex in pain processing.","author":"Ong","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.neuint.2006.01.020","article-title":"Group I metabotropic glutamate receptors activate the p70S6 kinase via both mammalian target of rapamycin (mTOR) and extracellular signal-regulated kinase (ERK 1\/2) signaling pathways in rat striatal and hippocampal synaptoneurosomes.","volume":"49","author":"Page","year":"2006","journal-title":"Neurochem. Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial.","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s002210050450","article-title":"Modulation of sensory inhibition in the ventrobasal thalamus via activation of group II metabotropic glutamate receptors by 2R, 4R-aminopyrrolidine-2, 4-dicarboxylate.","volume":"121","author":"Salt","year":"1998","journal-title":"Exp. Brain Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0028-3908(99)00092-1","article-title":"Pharmacological agents acting at subtypes of metabotropic glutamate receptors.","volume":"38","author":"Schoepp","year":"1999","journal-title":"Neuropharmacology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0412-17.2018","article-title":"Metabotropic glutamate receptor 2\/3 (mGluR2\/3) activation suppresses TRPV1 sensitization in mouse, but not human sensory neurons.","volume":"5","author":"Sheahan","year":"2018","journal-title":"eNeuro"},{"key":"B73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/B978-0-12-385952-5.00010-5","article-title":"Allosteric modulation of metabotropic glutamate receptors.","volume":"62","author":"Sheffler","year":"","journal-title":"Adv. Pharmacol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/cn200008d","article-title":"Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.","volume":"2","author":"Sheffler","year":"","journal-title":"ACS Chem. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0091-3057(02)00849-3","article-title":"Group II mGluR receptor agonists are effective in persistent and neuropathic pain models in rats.","volume":"73","author":"Simmons","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B76","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/317717a0","article-title":"Glutamate stimulates inositol phosphate formation in striatal neurones.","volume":"317","author":"Sladeczek","year":"1985","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuropharm.2004.10.014","article-title":"mGlu and NMDA receptor contributions to capsaicin-induced thermal and mechanical hypersensitivity.","volume":"48","author":"Soliman","year":"2005","journal-title":"Neuropharmacology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0014-2999(98)00098-3","article-title":"Inflammation alters the effects of mGlu receptor agonists on spinal nociceptive neurones.","volume":"347","author":"Stanfa","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0896-6273(92)90118-W","article-title":"A family of metabotropic glutamate receptors.","volume":"8","author":"Tanabe","year":"1992","journal-title":"Neuron"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8296501","article-title":"Amygdala plasticity and pain.","volume":"2017","author":"Thompson","year":"2017","journal-title":"Pain Res. Manag."},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1186\/s12990-015-0009-2","article-title":"N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans.","volume":"11","author":"Truini","year":"2015","journal-title":"Mol. Pain"},{"key":"B82","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2174\/1568007023339300","article-title":"Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics.","volume":"1","author":"Varney","year":"2002","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1073\/pnas.1416196112","article-title":"Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction.","volume":"112","author":"Walker","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B84","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2015.12.021","article-title":"In vitro pharmacological and rat pharmacokinetic characterization of LY3020371, a potent and selective mGlu2\/3 receptor antagonist.","volume":"115","author":"Witkin","year":"2017","journal-title":"Neuropharmacology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1021\/bi200129s","article-title":"\u201cMolecular switches\u201d on mGluR allosteric ligands that modulate modes of pharmacology.","volume":"50","author":"Wood","year":"2011","journal-title":"Biochemistry"},{"key":"B86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuropharm.2012.01.019","article-title":"CNS distribution of metabotropic glutamate 2 and 3 receptors: transgenic mice and [3H] LY459477 autoradiography.","volume":"66","author":"Wright","year":"2013","journal-title":"Neuropharmacology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-8-67","article-title":"NAAG peptidase inhibition in the periaqueductal gray and rostral ventromedial medulla reduces flinching in the formalin model of inflammation.","volume":"8","author":"Yamada","year":"2012","journal-title":"Mol. Pain"},{"key":"B88","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1460-9568.2004.03504.x","article-title":"Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.","volume":"20","author":"Yamamoto","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-4-31","article-title":"Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.","volume":"4","author":"Yamamoto","year":"2008","journal-title":"Mol. Pain"},{"key":"B90","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1460-9568.2006.05272.x","article-title":"Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.","volume":"25","author":"Yamamoto","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1523\/JNEUROSCI.22-15-06388.2002","article-title":"Peripheral group II metabotropic glutamate receptors (mGluR2\/3) regulate prostaglandin E2-mediated sensitization of capsaicin responses and thermal nociception.","volume":"22","author":"Yang","year":"2002","journal-title":"J. Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pain.2003.08.011","article-title":"Peripheral group II metabotropic glutamate receptors mediate endogenous anti-allodynia in inflammation.","volume":"106","author":"Yang","year":"2003","journal-title":"Pain"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.cellsig.2014.04.022","article-title":"Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.","volume":"26","author":"Yin","year":"2014","journal-title":"Cell. Signal."},{"key":"B94","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1523\/JNEUROSCI.1129-13.2014","article-title":"Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS.","volume":"34","author":"Yin","year":"2014","journal-title":"J. Neurosci."},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-6","article-title":"mGlu2 metabotropic glutamate receptors restrain inflammatory pain and mediate the analgesic activity of dual mGlu2\/mGlu3 receptor agonists.","volume":"7","author":"Zammataro","year":"2011","journal-title":"Mol. Pain"},{"key":"B96","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.brainresbull.2009.01.009","article-title":"Antinociceptive synergistic effect of spinal mGluR2\/3 antagonist and glial cells inhibitor on peripheral inflammation-induced mechanical hypersensitivity.","volume":"79","author":"Zhang","year":"2009","journal-title":"Brain Res. Bull."},{"key":"B97","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1124\/jpet.110.173112","article-title":"Functional plasticity of group II metabotropic glutamate receptors in regulating spinal excitatory and inhibitory synaptic input in neuropathic pain.","volume":"336","author":"Zhou","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2018.00383\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T01:10:49Z","timestamp":1539047449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnmol.2018.00383\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,9]]},"references-count":97,"alternative-id":["10.3389\/fnmol.2018.00383"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2018.00383","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,9]]},"article-number":"383"}}